Fund Holdings — Jones Hill Capital LP

Total Portfolio Value:
$589.17M
Total Bought:
$589.17M
Total Sold:
$0
Net Transaction:
+$589.17M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
BioMarin Pharmaceutical Inc.(BMRN)01,171,859+1,171,859$0$70.31M11.93%+$70.31M
BioCryst Pharmaceuticals, Inc.(BCRX)07,083,300+7,083,300$0$59.00M10.01%+$59.00M
Travere Therapeutics, Inc.(TVTX)0959,634+959,634$0$56.50M9.59%+$56.50M
Indivior Pharmaceuticals Inc(INDV)01,526,685+1,526,685$0$54.73M9.29%+$54.73M
Pharvaris N.V.(PHVS)0987,637+987,637$0$31.33M5.32%+$31.33M
Celcuity Inc.(CELC)0382,901+382,901$0$30.45M5.17%+$30.45M
Ionis Pharmaceuticals, Inc.(IONS)0599,826+599,826$0$26.78M4.55%+$26.78M
Supernus Pharmaceuticals0601,685+601,685$0$25.90M4.40%+$25.90M
Nuvation Bio Inc.CL A(NUVB)04,486,986+4,486,986$0$25.13M4.26%+$25.13M
Vera Therapeutics, Inc.CL A(VERA)0652,218+652,218$0$21.06M3.57%+$21.06M
Trevi Therapeutics, Inc.(TRVI)01,447,156+1,447,156$0$20.72M3.52%+$20.72M
Bicara Therapeutics Inc01,064,233+1,064,233$0$19.81M3.36%+$19.81M
Relmada Therapeutics Inc05,237,628+5,237,628$0$19.75M3.35%+$19.75M
ABIVAX Société AnonymeADS(ABVX)0142,558+142,558$0$14.12M2.40%+$14.12M
Aclaris Therapeutics Inc02,504,651+2,504,651$0$13.17M2.24%+$13.17M
Insmed Incorporated(INSM)0106,528+106,528$0$12.16M2.06%+$12.16M
Neurocrine Biosciences, Inc.(NBIX)083,426+83,426$0$11.83M2.01%+$11.83M
Immunocore Holdings plcADS(IMCR)0384,278+384,278$0$11.64M1.98%+$11.64M
Erasca, Inc.(ERAS)0610,118+610,118$0$8.94M1.52%+$8.94M
Capricor Therapeutics Inc0892,532+892,532$0$8.45M1.43%+$8.45M
Dianthus Therapeutics, Inc.(DNTH)080,017+80,017$0$7.05M1.20%+$7.05M
Neurogene Inc0217,700+217,700$0$6.06M1.03%+$6.06M
Corbus Pharmaceuticals Hldgs0886,428+886,428$0$6.05M1.03%+$6.05M
Tonix Pharmaceuticals Hldg C0563,739+563,739$0$5.49M0.93%+$5.49M
Sagimet Biosciences IncCOM SER A0502,587+502,587$0$4.97M0.84%+$4.97M
Dyne Therapeutics, Inc.(DYN)0300,900+300,900$0$4.85M0.82%+$4.85M
Avalyn Pharma Inc.(AVLN)0126,744+126,744$0$3.61M0.61%+$3.61M
Attovia Therapeutics Inc0182,295+182,295$0$3.12M0.53%+$3.12M
Phathom Pharmaceuticals Inc0276,830+276,830$0$2.02M0.34%+$2.02M
Lexeo Therapeutics Inc0593,737+593,737$0$2.01M0.34%+$2.01M
Olema Pharmaceuticals Inc0206,397+206,397$0$1.78M0.30%+$1.78M
Tenax Therapeutics Inc0122,169+122,169$0$230.9K0.04%+$230.9K
Alvotech(ALVO)026,700+26,700$0$154.9K0.03%+$154.9K
Page 1 of 1
Jones Hill Capital LP — 13F Holdings — Q3 2026 | TickerTrail